Ubie has taken the lead in implementing a new standard of measurement to evaluate health and economic impact for global digital health startups The framework uses the pharmaceutical industry's standard of Quality-Adjusted Life Years (QALY) to provide a widely-accepted and transparent impact measurement Preliminary results support the ability of Ubie's AI Symptom Checker to deliver early intervention for patients through differential diagnoses to improve outcomes NEW YORK , Aug. 22, 2024 /PRNewswire/ -- Ubie , a global healthcare AI platform that enhances the intersection of patients, providers, and life sciences, today unveiled a comprehensive logic model and social impact framework designed to measure and disclose the health and economic outcomes generated by digital health innovation. A preliminary assessment of over 1.
5 million Ubie users showed that Ubie's AI Symptom Checker platform contributed patient quality-adjusted life years (QALY) by an estimated 27,000 years (from 2021 to 2024), and created approximately $1 billion in economic value. Historically, the digital health startup landscape has been limited in its ability to measure the social impact of products and platforms, aside from sales numbers. Measurement rules and definitions are ambiguous, providing little insight for health systems, health companies and pharmaceutical partners.
Ubie approached the framework with the aim of contributing and building on reliable and widely understood methods for measuring socia.